<?xml version="1.0" encoding="UTF-8"?>
<p id="Par38">These results clearly support the capacity of compound 
 <bold>#7</bold> to inhibit HIV and synergize with selected clinical drugs, including reverse transcriptase inhibitors and integrase inhibitors, in HIV-exposed cells. Thus they encourage future studies addressing the physiological relevance of the synergisms and detailed analysis of potentially complex combinatorial compound effects
 <sup>
  <xref ref-type="bibr" rid="CR24">24</xref>,
  <xref ref-type="bibr" rid="CR25">25</xref>
 </sup>.
</p>
